First look: how a new drug behaves in people with kidney issues
NCT ID NCT06295796
Summary
This study aimed to understand how moderate to severe kidney problems affect how the body processes an experimental drug called MK-8527. It involved 18 people, some with kidney impairment and some with healthy kidneys, who each received a single dose. Researchers measured how much of the drug stayed in the body and for how long, and checked for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research by Design ( Site 0001)
Chicago, Illinois, 60643, United States
Conditions
Explore the condition pages connected to this study.